VMP 41760211000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Ciprofloxacin 250mg/5ml oral suspension
BNF code 0501120L0AABGBG
Virtual Therapeutic Moiety Ciprofloxacin
Date identifier became valid 9 May 2023
Previous product identifier 324602005
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure spoonful
Virtual Product Ingredient
Ingredient Ciprofloxacin
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Oral suspension
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Ciprofloxacin 250mg/5ml oral suspension (Drugsrus Ltd)
Ciproxin 250mg/5ml oral suspension (Bayer Plc)
Ciproxin 250mg/5ml oral suspension (Lexon (UK) Ltd)
Ciproxin 250mg/5ml oral suspension (Necessity Supplies Ltd)
Virtual Medicinal Product Packs
Ciprofloxacin 250mg/5ml oral suspension 100 ml
Ciprofloxacin 250mg/5ml oral suspension 30 ml

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback